Mark's Story



From Zero Options to an MSK Clinical Trial That Gave Mark New Hope

After six years of living with thyroid cancer, Mark’s disease developed a resistance, and his treatment stopped working. That’s when Mark turned to MSK and enrolled in a new, breakthrough clinical trial – one supported by philanthropy.

If I was putting my money down on any kind of hospital or research, this is the place I would do it. And I do."


  MSK Patient and Donor